AbbVie Inc. (ABBV) vs Walmart Inc. (WMT)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Founded in 1962, Walmart Inc. has grown into the world’s largest retailer, operating more than 10,700 stores worldwide, including about 4,600 Walmart locations in the United States and roughly 600 Sam’s Club warehouses, while continuing to expand its e-commerce business. The company serves around 270 million customers each week and generated over $680 billion in fiscal 2025 revenue. Walmart’s operations are organized into three reporting segments: Walmart U.S., which accounted for 68% of fiscal 2025 sales, Walmart International at 18%, and Sam’s Club at 14%. In the U.S., nearly 60% of Walmart’s $465 billion in fiscal 2025 revenue came from grocery sales, with about one-quarter generated by general merchandise. Internationally, the company’s business is primarily concentrated in Mexico, with additional emerging exposure to India.